| Method of imputing days supply | |||||
---|---|---|---|---|---|---|
 | Unadjusted | 2.0-2.1 variable factor†| 2.0 Constant Factor 45 Minimum‡ | |||
Variable* | Odds ratio | P value | Odds ratio | P value | Odds ratio | P value |
Logistic regression of persistence on index drug | ||||||
Bimatoprost | 0.66 | < 0.001 | 0.74 | < 0.001 | 0.71 | < 0.001 |
Travoprost | 0.66 | < 0.001 | 0.64 | < 0.001 | 0.66 | < 0.001 |
Female | 0.99 | 0.889 | 0.97 | 0.545 | 0.96 | 0.423 |
Age 55 to 64 years | 1.12 | 0.088 | 1.19 | 0.003 | 1.17 | 0.010 |
Age 65 to 74 years | 1.21 | 0.009 | 1.27 | < 0.001 | 1.24 | 0.001 |
Age 75+ years | 1.10 | 0.204 | 1.14 | 0.057 | 1.16 | 0.025 |
Ocular hypertension | 0.99 | 0.886 | 1.00 | 0.920 | 1.00 | 0.933 |
Linear regression of days coverage on index drug | ||||||
 | Coefficient | P value | Coefficient | P value | Coefficient | P value |
Bimatoprost | -21.60 | < 0.001 | -21.03 | < 0.001 | -28.85 | < 0.001 |
Travoprost | -32.84 | < 0.001 | -42.11 | < 0.001 | -39.44 | < 0.001 |
Female | 0.33 | 0.866 | -0.56 | 0.833 | -0.42 | 0.873 |
Age 55 to 64 years | 12.67 | < 0.001 | 17.17 | < 0.001 | 16.21 | < 0.001 |
Age 65 to 74 years | 22.40 | < 0.001 | 26.50 | < 0.001 | 26.09 | < 0.001 |
Age 75+ years | 10.87 | < 0.001 | 11.18 | 0.004 | 14.49 | < 0.001 |
Ocular hypertension | 2.31 | 0.241 | -0.01 | 0.997 | -0.17 | 0.950 |
Intercept | 128.94 | < 0.001 | 226.28 | < 0.001 | 235.24 | < 0.001 |